Christopher Loose
2022
In 2022, Christopher Loose earned a total compensation of $1.5M as Former Chief Scientific Officer at Korro Bio.
Compensation breakdown
| Non-Equity Incentive Plan | $192,138 |
|---|---|
| Option Awards | $226,580 |
| Salary | $480,344 |
| Stock Awards | $604,500 |
| Other | $15,250 |
| Total | $1,518,812 |
Loose received $604.5K in stock awards, accounting for 40% of the total pay in 2022.
Loose also received $192.1K in non-equity incentive plan, $226.6K in option awards, $480.3K in salary and $15.3K in other compensation.
Rankings
In 2022, Christopher Loose's compensation ranked 2,199th out of 5,676 executives tracked by ExecPay. In other words, Loose earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,199 out of 5,676 | 61st |
Division Manufacturing | 1,184 out of 3,084 | 62nd |
Major group Chemicals And Allied Products | 509 out of 1,399 | 64th |
Industry group Drugs | 469 out of 1,300 | 64th |
Industry Pharmaceutical Preparations | 340 out of 942 | 64th |
Source: SEC filing on April 29, 2024.
Loose's colleagues
We found three more compensation records of executives who worked with Christopher Loose at Korro Bio in 2022.